Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation

Cristina Rubiolo, Daniela Piazzolla, Katrin Meissl, Hartmut Beug, Johannes C. Huber, Andrea Kolbus, Manuela Baccarini

Blood (2006) 108 (1): 152–159.

https://doi.org/10.1182/blood-2005-09-3866

Published: 2006

Journal Articles

Results of a Multicenter Phase II Trial for Older Patients with c-Kit Positive Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS) Using Low-Dose Ara-C (LDAC) and Imatinib.

F. Heidel, MD, J. Cortes, MD, F. Ruecker, MD, M. Kaufmann, MD, W. Aulitzky, MD, L. Letvak, MD, T. Kindler, MD, C. Huber, MD, H. Dohner, MD, H. Kantarjian, MD, T. Fischer, MD

Blood (2005) 106 (11): 1853.

https://doi.org/10.1182/blood.V106.11.1853.1853

Published: 2005

Journal Articles

Mechanisms of Resistance to the FLT3-Tyrosine Kinase Inhibitor PKC412 in Patients with AML.

F. Heidel, F. Breitenbuecher, T. Kindler, F. K. Solem, B. Carius, H.-M. Thiede, P. S. Cohen, J. Roesel, E. H. Estey, E. Feldman, G. Ehninger, G. J. Schiller, V. Klimek, S. Nimer, D. DeAngelo, F. Giles, R. M. Stone, C. Huber, T. Fischer

Blood (2004) 104 (11): 454.

https://doi.org/10.1182/blood.V104.11.454.454

Published: 2004

Journal Articles

Efficacy of Rituximab Combined in Salvage- and High Dose-Therapy (HDT) for Patients with Relapsed NHL; Interim Analysis of a Multicenter Phase II Study.

G. Hess, MD, T. Flohr, MD, N. Frickhofen, MD, H. Wolf, MD, M. Gramatzki, MD, H. Link, MD, N. Peter, MD, N. Basara, MD, N. Schmitz, MD, A. Banat, MD, M. Kneba, MD, C. Huber, MD, G. Derigs, MD

Blood (2004) 104 (11): 1325.

https://doi.org/10.1182/blood.V104.11.1325.1325

Published: 2004

Journal Articles

Clinical Course and Significance of the Novel FLT3-Y842C Mutation in a Patient with AML Treated with PKC412 Monotherapy.

T. Kindler, F. Breitenbuecher, S. Kasper, E. Estey, F. Giles, E. Feldman, G. Ehninger, G. Schiller, V. Klimek, S. D. Nimer, A. Gratwohl, C. Choudhary, C. Mueller-Tidow, H. Serve, H. Gschaidmeier, P. S. Cohen, C. Huber, T. Fischer

Blood (2004) 104 (11): 2537.

https://doi.org/10.1182/blood.V104.11.2537.2537

Published: 2004

Journal Articles

Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes

MJ Aman, T Tretter, I Eisenbeis, G Bug, T Decker, WE Aulitzky, H Tilg, C Huber, C Peschel

Blood (1996) 87 (11): 4731–4736.

https://doi.org/10.1182/blood.V87.11.4731.bloodjournal87114731

Published: 1996

Journal Articles

Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3

K Geissler, C Peschel, D Niederwieser, H Strobl, J Goldschmitt, L Ohler, P Bettelheim, P Kahls, C Huber, K Lechner, P Hocker, K Kolbe

Blood (1996) 87 (7): 2732–2739.

https://doi.org/10.1182/blood.V87.7.2732.bloodjournal8772732

Published: 1996

Journal Articles

Role of accessory cells in cytokine production by T cells in chronic B- cell lymphocytic leukemia

T Decker, T Flohr, P Trautmann, MJ Aman, W Holter, O Majdic, C Huber, C Peschel

Blood (1995) 86 (3): 1115–1123.

https://doi.org/10.1182/blood.V86.3.1115.1115

Published: 1995

Journal Articles

Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist

MJ Aman, U Keller, G Derigs, M Mohamadzadeh, C Huber, C Peschel

Blood (1994) 84 (12): 4142–4150.

https://doi.org/10.1182/blood.V84.12.4142.bloodjournal84124142

Published: 1994

Journal Articles

Human interleukin-4 enhances stromal cell-dependent hematopoiesis: costimulation with stem cell factor

U Keller, MJ Aman, G Derigs, C Huber, C Peschel

Blood (1994) 84 (7): 2189–2196.

https://doi.org/10.1182/blood.V84.7.2189.2189

Published: 1994

Journal Articles

Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells

MJ Aman, G Rudolf, J Goldschmitt, WE Aulitzky, C Lam, C Huber, C Peschel

Blood (1993) 82 (8): 2371–2378.

https://doi.org/10.1182/blood.V82.8.2371.2371

Published: 1993

Journal Articles

Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies

EU Irschick, F Hladik, D Niederwieser, W Nussbaumer, E Holler, E Kaminski, C Huber

Blood (1992) 79 (6): 1622–1628.

https://doi.org/10.1182/blood.V79.6.1622.1622

Published: 1992

Journal Articles

Minimal interferon-alpha doses for hairy cell leukemia [letter; comment]

G Gastl, W Aulitzky, H Tilg, J Thaler, M Berger, C Huber

Blood (1990) 75 (3): 812–813.

https://doi.org/10.1182/blood.V75.3.812.812

Published: 1990

Journal Articles

Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions

W Hinterberger, G Adolf, P Bettelheim, K Geissler, C Huber, E Irschick, P Kalhs, U Koller, K Lechner, B Meister

Blood (1989) 74 (8): 2713–2717.

https://doi.org/10.1182/blood.V74.8.2713.2713

Published: 1989

Journal Articles

Further evidence for lymphokine overproduction in severe aplastic anemia [see comments]

W Hinterberger, G Adolf, G Aichinger, R Dudczak, K Geissler, P Hocker, C Huber, P Kalhs, W Knapp, U Koller

Blood (1988) 72 (1): 266–272.

https://doi.org/10.1182/blood.V72.1.266.266

Published: 1988

Journal Articles

Human large granular lymphocytes and their relationship to natural killer cell activity in various disease states

G Gastl, D Niederwieser, C Marth, H Huber, D Egg, G Schuler, R Margreiter, H Braunsteiner, C Huber

Blood (1984) 64 (1): 288–295.

https://doi.org/10.1182/blood.V64.1.288.288

Published: 1984

Journal Articles

Prognostic significance of lymphocyte density distribution profiles in adult non-Hodgkin lymphomas

C Huber, D Lutz, D Niederwieser, G Weiser, O Dietze, H Theml, H Braunsteiner

Blood (1982) 60 (6): 1397–1401.

https://doi.org/10.1182/blood.V60.6.1397.1397

Published: 1982

Journal Articles

Expression and specificity of FcIgG receptor sites on neoplastic lymphocytes

C Huber, HD Flad, K Nilsson, H Wigzell, G Michlmayr, H Frischauf, H Braunsteiner

Blood (1978) 52 (5): 911–921.

https://doi.org/10.1182/blood.V52.5.911.911

Published: 1978

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation

Results of a Multicenter Phase II Trial for Older Patients with c-Kit Positive Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS) Using Low-Dose Ara-C (LDAC) and Imatinib.

Mechanisms of Resistance to the FLT3-Tyrosine Kinase Inhibitor PKC412 in Patients with AML.

Efficacy of Rituximab Combined in Salvage- and High Dose-Therapy (HDT) for Patients with Relapsed NHL; Interim Analysis of a Multicenter Phase II Study.

Clinical Course and Significance of the Novel FLT3-Y842C Mutation in a Patient with AML Treated with PKC412 Monotherapy.

Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes

Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3

Role of accessory cells in cytokine production by T cells in chronic B- cell lymphocytic leukemia

Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist

Human interleukin-4 enhances stromal cell-dependent hematopoiesis: costimulation with stem cell factor

Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells

Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies

Minimal interferon-alpha doses for hairy cell leukemia [letter; comment]

Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions

Further evidence for lymphokine overproduction in severe aplastic anemia [see comments]

Human large granular lymphocytes and their relationship to natural killer cell activity in various disease states

Prognostic significance of lymphocyte density distribution profiles in adult non-Hodgkin lymphomas

Expression and specificity of FcIgG receptor sites on neoplastic lymphocytes

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only